HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
HARROW, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$27.68+0.40 (+1.47%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
HARROW, INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Branded | $195.76M | $116.12M | $50.26M | – | – | – | – | – | – | 71.9% | +68.6% |
| ImprimisRx [Member] | $76.55M | $83.50M | $79.94M | – | – | – | – | – | – | 28.1% | -8.3% |
| Pharmaceutical Compounding [Member] | – | – | – | – | $72.48M | $48.87M | $51.17M | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Branded | $53.54M | $29.26M | $18.83M | – | – | – | – | – | – | +83.0% |
| ImprimisRx [Member] | $15.12M | $31.93M | $22.78M | – | – | – | – | – | – | -52.6% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product sales, net | $271.91M | $198.62M | $117.45M | $83.52M | $69.10M | $48.48M | $51.14M | $41.33M | $26.68M | 99.9% | +36.9% |
| VEVYE | $88.69M | $28.06M | $1.77M | – | – | – | – | – | – | 32.6% | +216.1% |
| IHEEZO | $81.35M | $49.30M | $20.62M | – | – | – | – | – | – | 29.9% | +65.0% |
| Other branded products | $25.33M | $37.84M | $15.13M | – | – | – | – | – | – | 9.3% | -33.1% |
| Other revenues | $394.00K | $995.00K | $12.75M | $5.07M | $3.37M | $392.00K | $28.00K | – | – | 0.1% | -60.4% |
| Other Revenue [Member] | $394.00K | $915.00K | $12.75M | – | – | – | – | – | – | 0.1% | -56.9% |
| License Revenues [Member] | – | – | – | – | – | – | $28.00K | $38.00K | $90.00K | – | – |
| License [Member] | – | – | – | – | $20.00K | $36.00K | $28.00K | – | – | – | – |
| Commissions [Member] | – | – | – | $3.87M | $3.25M | $356.00K | – | – | – | – | – |
| Transfer of Profit [Member] | – | – | – | $1.21M | $99.00K | – | – | – | – | – | – |
| Transfer Of Acquired Product Sales Profits [Member] | – | $995.00K | $12.75M | $1.21M | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Harrow's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.